Webinar Date/Time: Wednesday, April 26th, 2023 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Nitrosamine impurities are classified as “cohort of concern” as per ICH-M7 guidelines. Regulatory agencies recommend steps manufacturers of APIs and drug products should take to detect and prevent unacceptable levels of nitrosamine impurities in pharmaceutical products. Regulatory also published analytical testing methods to provide guidance to industry to evaluate mutagenic nitrosamine impurities in many drug substances and drug products. LC/MS/MS inherently is selective and sensitive analytical technique that is well-suited to identify and quantify nitrosamine impurities at very low levels. In this webcast, we will discuss on the conventional nitrosamines and nitroso drug substance related impurities (NDSRIs), their analysis using LC-MS/MS, analytical challenges, and the available solutions from Agilent.
Register Free: https://www.chromatographyonline.com/lcgc_w/nitrosamine
Event Overview:
Nitrosamine impurities are classified as “cohort of concern” as per ICH-M7 guidelines. Regulatory agencies recommend steps manufacturers of APIs and drug products should take to detect and prevent unacceptable levels of nitrosamine impurities in pharmaceutical products. Regulatory also published analytical testing methods to provide guidance to industry to evaluate mutagenic nitrosamine impurities in many drug substances and drug products. LC/MS/MS inherently is selective and sensitive analytical technique that is well-suited to identify and quantify Nitrosamine impurities at very low levels. In this webcast, we will discuss on the conventional nitrosamines and Nitroso drug substance related impurities (NDSRIs), their analysis using LC-MS/MS, analytical challenges, and the available solutions from Agilent.
Key Learning Objectives:
Who Should Attend:
Speaker:
Prasanth Joseph, PhD
Chromatography Mass spectrometry Product Specialist
Agilent Technologies
Prasanth Joseph joined Agilent in 2015 as application Engineer for LC-MS/MS and has 19 years of experience in the analytical instrumentation industry, specializes in small molecule applications. He received his PhD in Environmental Science from Bharathiar University, India. He also has master’s degree in business administration from the University of Buckingham, UK.
Prasanth Joseph developed many analytical methods in LC-MS/MS to quantify genotoxic impurities in drug substance and products, analysis of extractables and leachables in pharma and food packaging and medical devices and Bioavailability and Bioequivalence (BA/BE) studies in clinical trials. He provided guidance in developing LC-MS workflows for impurity profiling of pharmaceuticals and metabolite identification (MetID) and quantification as a part of ADME/DMPK related studies.
Prasanth Joseph is also well versed with analysis of phytochemicals in botanicals and herbal extracts, food residue screening, and quantitation and analysis of contaminants in environmental samples.
Register Free: https://www.chromatographyonline.com/lcgc_w/nitrosamine
Quantifying Microplastics in Meconium Samples Using Pyrolysis–GC-MS
March 26th 2025Using pyrolysis-gas chromatography and mass spectrometry, scientists from Fudan University and the Putuo District Center for Disease Control and Prevention detected and quantified microplastics in newborn stool samples.
The Role of SPME Combined with GC–MS for PFAS Analysis
Published: March 25th 2025 | Updated: March 25th 2025Emanuela Gionfriddo and Madison Williams from University at Buffalo, the State University of New York, NY, USA discuss the important role that solid-phase microextraction (SPME) techniques with gas chromatography mass spectrometry (GC–MS) can play in the analysis of per- and polyfluoroalkyl substances (PFAS).
Multi-Step Preparative LC–MS Workflow for Peptide Purification
March 21st 2025This article introduces a multi-step preparative purification workflow for synthetic peptides using liquid chromatography–mass spectrometry (LC–MS). The process involves optimizing separation conditions, scaling-up, fractionating, and confirming purity and recovery, using a single LC–MS system. High purity and recovery rates for synthetic peptides such as parathormone (PTH) are achieved. The method allows efficient purification and accurate confirmation of peptide synthesis and is suitable for handling complex preparative purification tasks.